Edgewell Personal Care logo

Edgewell Personal Care

EPC | NYSE
Chart Builder DCF Calculator
$27.55
+$0.47 (+1.74%)
Sep 22, 2026, 11:52 AM ET · Market open
TTM
Period Ending
Q3 2026
Jun 29, 2026
Q2 2026
Mar 30, 2026
Q1 2026
Dec 30, 2025
Q4 2025
Sep 29, 2025
Q3 2025
Jun 29, 2025
Q2 2025
Mar 30, 2025
Q1 2025
Dec 30, 2024
Q4 2024
Sep 29, 2024
Q3 2024
Jun 29, 2024
Q2 2024
Mar 30, 2024
Q1 2024
Dec 30, 2023
Q4 2023
Sep 29, 2023
Q3 2023
Jun 29, 2023
Q2 2023
Mar 30, 2023
Q1 2023
Dec 30, 2022
Q4 2022
Sep 29, 2022
Q3 2022
Jun 29, 2022
Q2 2022
Mar 30, 2022
Q1 2022
Dec 30, 2021
Q4 2021
Sep 29, 2021
Q3 2021
Jun 29, 2021
Q2 2021
Mar 30, 2021
Q1 2021
Dec 30, 2020
Revenue
2.05B 2.11B 2.17B 2.22B 2.2B 2.22B 2.24B 2.25B 2.27B 2.27B 2.27B 2.25B 2.25B 2.23B 2.18B 2.17B 2.18B 2.13B 2.1B 2.09B 2.03B 1.94B 1.95B
Cost of Revenue
1.21B 1.24B 1.27B 1.3B 1.27B 1.28B 1.29B 1.3B 1.3B 1.31B 1.32B 1.31B 1.32B 1.34B 1.3B 1.29B 1.27B 1.19B 1.15B 1.14B 1.1B 1.06B 1.06B
Gross Profit
837.7M 863.7M 894.3M 924.9M 929.1M 947.7M 949.6M 955.7M 973.3M 966.5M 950.7M 942.6M 931M 891.3M 879.1M 879.4M 905.4M 935.1M 946.7M 950.1M 928.4M 880.8M 882.1M
Operating Income
34M 62.7M 75.5M 96.6M 153.3M 182.3M 193.5M 199.3M 232.8M 236.3M 223M 228.8M 232.7M 196.4M 181.3M 181.2M 186.6M 207.8M 229M 238.8M 216.9M 189.3M 180.5M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-64.2M -45M -11.6M 23.6M 82.2M 107.5M 113.2M 120.9M 150.6M 158.9M 138.5M 149.5M 157.8M 123.3M 123.8M 123M 127M 144.6M 137M 146M 122.8M 74.2M 82.9M
Net Income
-93.2M -77.8M -38.2M 25.4M 64.8M 84.7M 91.7M 98.6M 121.1M 125.1M 108.5M 116.1M 118.5M 96M 99.8M 98.6M 109M 119.3M 110.5M 117M 93.9M 57.8M 62.9M
Selling & General & Admin
579.8M 656.3M 666.5M 671.7M 662.5M 664.4M 663.8M 662.1M 661.7M 651.3M 648.8M 638.9M 625.5M 622.4M 625.5M 627M 644.7M 650.9M 641.5M 632.7M 626.8M 606.2M 612.9M
Research & Development
57.8M 58.5M 57.5M 57.6M 58.1M 58.7M 59M 58.4M 58M 58.2M 58.4M 58.5M 58M 56.8M 56.1M 55.5M 55.3M 56.3M 56.9M 57.8M 57.8M 55.6M 55.2M
Other Expenses
166.1M 86.2M 94.8M 99M 55.2M 42.3M 33.3M 35.9M 20.8M 20.7M 20.5M 16.4M 14.8M 15.7M 16.2M 15.7M 18.8M 20.1M 19.3M 20.8M 26.9M 29.7M 33.5M
Operating Expenses
803.7M 801M 818.8M 828.3M 775.8M 765.4M 756.1M 756.4M 740.5M 730.2M 727.7M 713.8M 698.3M 694.9M 697.8M 698.2M 718.8M 727.3M 717.7M 711.3M 711.5M 691.5M 701.6M
Interest Expense
68.7M 71.4M 73.7M 73.2M 75.9M 75.3M 75.5M 76.5M 77.7M 78.1M 78.4M 78.5M 77.9M 76.7M 74M 71.4M 70.1M 68.5M 67.8M 67.9M 68.6M 67.7M 64.3M
Selling & Marketing Expenses
154.7M 235.1M 242M 246.7M 240.3M 236.5M 234.1M 232M 228.2M 231.6M 231.4M 229.1M 230.1M 231M 238M 238.3M 247M 248M 246.5M 241.5M 252.1M 237.7M 216.3M
Cost & Expenses
2.02B 2.04B 2.09B 2.13B 2.05B 2.04B 2.05B 2.05B 2.04B 2.04B 2.05B 2.02B 2.02B 2.03B 2B 1.99B 1.99B 1.92B 1.87B 1.85B 1.82B 1.75B 1.77B
Income Tax Expense
-20.7M -18.3M -9.9M -1.8M 17.4M 22.8M 21.5M 22.3M 29.5M 33.8M 30M 33.4M 39.3M 27.3M 24M 24.4M 18M 25.3M 26.5M 29M 28.9M 16.4M 20M
Shares Outstanding (Basic)
46.1M 46.5M 46.6M 46.5M 47.8M 48M 48.7M 49.7M 49.5M 49.8M 50.1M 50.6M 51.1M 52.43M 51.6M 51.8M 52.5M 53.6M 54.4M 54.4M 54.4M 54.3M 54.4M
Shares Outstanding (Diluted)
46.6M 46.5M 46.6M 46.5M 48M 48.2M 48.7M 50.1M 50.1M 50.2M 50.5M 51.3M 51.8M 52M 51.9M 52.5M 53.1M 54.3M 55M 55.4M 55.4M 54.9M 54.8M
EPS (Basic)
-2 -1.69 -0.86 0.51 1.35 1.73 1.85 1.99 2.39 2.43 2.08 2.21 2.28 1.83 1.89 1.87 2.03 2.20 2.03 2.15 1.73 1.07 1.17
EPS (Diluted)
-2.01 -1.69 -0.86 0.51 1.35 1.72 1.84 1.98 2.36 2.39 2.05 2.18 2.25 1.81 1.87 1.84 2 2.17 2 2.12 1.70 1.05 1.15
EBITDA
55M 112.2M 150.5M 185.6M 245.1M 269.4M 275.9M 285.4M 318.2M 327.7M 308.3M 319.4M 326.6M 290.9M 288.8M 284.3M 285.4M 300.4M 291.1M 301M 290.3M 240.3M 245.4M
EBIT
-14.9M 26.4M 62.1M 96.8M 158.1M 182.8M 188.7M 197.4M 228.3M 237M 216.9M 228M 235.7M 200M 197.8M 194.4M 197.1M 213.1M 204.8M 213.9M 206.3M 156.8M 162.1M
Depreciation & Amortization
69.9M 85.8M 88.4M 88.8M 87M 86.6M 87.2M 88M 89.9M 90.7M 91.4M 91.4M 90.9M 90.9M 91M 89.9M 88.3M 87.3M 86.3M 87.1M 84M 83.5M 83.3M

© 2026 bestshares.com. All rights reserved.